MTF treatment of ovarian cancer cells enhanced activation of the mitochondrial deacetylase sirtuin 3 (SIRT3) and intensified MTF-initiated apoptosis, energy stress, and mitochondrial malfunction, and, furthermore, increased AMPK overexpression [65]. This evidence concerns the gene PRKAA2 and ovarian carcinoma.